These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33858493)

  • 1. Stereotactic cisternal lavage in patients with aneurysmal subarachnoid hemorrhage with urokinase and nimodipine for the prevention of secondary brain injury (SPLASH): study protocol for a randomized controlled trial.
    Roelz R; Schubach F; Coenen VA; Jenkner C; Scheiwe C; Grauvogel J; Niesen WD; Urbach H; Taschner C; Seufert J; Kätzler J; Beck J; Reinacher PC
    Trials; 2021 Apr; 22(1):285. PubMed ID: 33858493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Stereotactic Ventriculocisternostomy on Delayed Cerebral Infarction and Outcome After Subarachnoid Hemorrhage.
    Roelz R; Schaefer JH; Scheiwe C; Sajonz B; Csok I; Steiert C; Buttler J; Rohr E; Grauvogel J; Shah MJ; Egger K; Niesen WD; Bardutzky J; Beck J; Coenen VA; Reinacher PC
    Stroke; 2020 Feb; 51(2):431-439. PubMed ID: 31795898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Catheter Ventriculocisternostomy for Clearance of Subarachnoid Hemorrhage in Patients with Coiled Aneurysms.
    Roelz R; Scheiwe C; Urbach H; Coenen VA; Reinacher P
    Oper Neurosurg (Hagerstown); 2018 Mar; 14(3):231-235. PubMed ID: 28582545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
    Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL;
    Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early cisternal fibrinolysis is more effective than rescue spasmolysis for the prevention of delayed infarction after subarachnoid haemorrhage.
    Roelz R; Scheiwe C; Grauvogel J; Csok I; Coenen VA; Beck J; Reinacher PC
    Stroke Vasc Neurol; 2022 Apr; 7(2):108-113. PubMed ID: 34750281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel rescue therapy for cerebral vasospasm: Cisternal Nimodipine application via stereotactic catheter ventriculocisternostomy.
    Roelz R; Scheiwe C; Coenen VA; Reinacher PC
    J Clin Neurosci; 2019 May; 63():244-248. PubMed ID: 30737093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of stereotactic catheter ventriculocisternostomy for cisternal lavage therapy in patients with subarachnoid hemorrhage.
    Reinacher PC; Coenen VA; Kraeutle R; Scheiwe C; Jabbarli R; Roelz R
    Clin Neurol Neurosurg; 2017 Dec; 163():94-102. PubMed ID: 29096139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Catheter Ventriculocisternostomy for Clearance of Subarachnoid Hemorrhage: A Matched Cohort Study.
    Roelz R; Coenen VA; Scheiwe C; Niesen WD; Egger K; Csok I; Kraeutle R; Jabbarli R; Urbach H; Reinacher PC
    Stroke; 2017 Oct; 48(10):2704-2709. PubMed ID: 28904239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisternal lavage via third ventriculostomy through the fenestrated lamina terminalis after aneurysm clipping: Technical note.
    Roelz R; Grauvogel J; Scheiwe C; Shah M; Beck J; Reinacher PC; Hubbe U
    J Clin Neurosci; 2019 Jun; 64():283-286. PubMed ID: 30922533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage.
    Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI
    Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial.
    Lin F; Li R; Chen Y; Yang J; Wang K; Jia Y; Han H; Hao Q; Shi G; Wang S; Zhao Y; Chen X
    Trials; 2024 Jun; 25(1):377. PubMed ID: 38863026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
    BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage.
    Zhao B; Yang H; Zheng K; Li Z; Xiong Y; Tan X; Zhong M;
    J Neurosurg; 2017 Jun; 126(6):1764-1771. PubMed ID: 27367238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
    Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M
    Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Mayer SA; Bruder N; Citerio G; Defreyne L; Dubois C; Gupta R; Higashida R; Marr A; Nguyen TN; Roux S; Smrčka M; Torné RT; Aldrich EF;
    J Neurosurg; 2024 Aug; ():1-12. PubMed ID: 39126720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis.
    Grossen AA; Ernst GL; Bauer AM
    Neurosurg Focus; 2022 Mar; 52(3):E10. PubMed ID: 35231885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
    Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL;
    Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage.
    Etminan N; Macdonald RL; Davis C; Burton K; Steiger HJ; Hänggi D
    Acta Neurochir Suppl; 2015; 120():281-6. PubMed ID: 25366637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan.
    Post R; Germans MR; Coert BA; Rinkel GJE; Vandertop WP; Verbaan D
    Trials; 2020 Feb; 21(1):199. PubMed ID: 32070395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.